Saratov JOURNAL of Medical and Scientific Research

Cardiac remodeling in patients with chronic kidney disease

Year: 2019, volume 15 Issue: №2 Pages: 217-221
Heading: Internal Diseases Article type: Review
Authors: Sedov D.S., Rebrov А.Р.
Organization: Saratov State Medical University

The duration and quality of life of patients undergoing extracorporeal renal replacement therapy are largely dependent on concomitant diseases and conditions. Cardiovascular disease is a significant complication of chronic kidney disease and a major cause of death in patients undergoing hemodialysis. Cardiovascular remodeling is an independent predictor of the risk of cardiovascular events in patients with chronic kidney disease (CKD), including those in the dialysis stage. This paper analyzes the literature on left ventricular myocardial remodeling in the late predialysis stages of CKD and in patients receiving treatment with chronic hemodialysis.

1 Chandrashekar A, Ramakrishnan S, Rangarajan D. Survival analysis of patients on maintenance hemodialysis. Indian Journal of Nephrology 2014; 24 (4): 206-13
2 Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2012 Annual Data Report. (1 -476). Am J Kidney Dis 2013; 61: 7
3 Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808
4 Kichigin VA, Kozlov DO, Kikh OV, Volkova ТА. Survival of the patients receiving a chronic hemodialysis (review). Acta Med-ica Eurasica 2018; 1: 22-9
5 McCullough PA, Chan CT, Weinhandl ED, et al. Intensive Hemodialysis, Left Ventricular Hypertrophy, a Cardiovascular Disease. Am J Kidney Dis 2016; 68: S5-S14. DOI: 10.1053/j. ajkd.2016.05.025
6 Kim H, Kim KH, Ahn SV, et al. Risk of major cardiovascular events amongincident dialysis patients: A Korean national population-based study. Int J Cardiol 2015; 198: 95-101
7 Saran R, Li Y, Robinson B, et al. US Renal Data System 2014 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2015; 66(1) (suppl 1): S1-305
8 Suleymanlar G, Serdengecti K, Altiparmak MR, et al. Turkish registry of nephrology, dialysis, and transplantation: Trends in renal replacement therapy in Turkey, 1996-2008. Am J Kidney Dis 2011; 57: 456-65
9 Paoletti E, De NL, Gabbai FB, et al. Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephrol 2016; 11: 271-9. DOI: 10.2215/CJN.06980615
10 Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end- stage renal disease. Kidney Int 1989; 36 (2): 286-90
11 Wang AY-M, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15 (8): 2186-94
12 Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004; 65 (4): 1492-8
13 Gibbons GH, Dzau VJ. The emerging concepr of vascular remodeling. N Engl J Med 1994; 330: 1431-8
14 Poddubny DA, Rebrov AP. Hypertrophy and remodeling of the left ventricle of the patients with ankylosingspondy-litis: the role of endothelial dysfunction. Siberian medical magazine (Irkutsk) 2007; 74 (7): 73-7
15 Schwarz U, Buzello М, Ritz Е, etal. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-23
16 Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet 2016; 388: 276-84
17 Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta 2010 Oct 9; 411 (19-20): 1412-20. DOI: 10.1016/j.cca.2010.06.019
18 Gomez AT, Kiberd BA, Royston JP, et al. Comorbidity burden at dialysis initiation and mortality: A cohort study. Can J Kidney Health Dis2015; 2: 34 DOI: 10.1186/s40697-015-0068-3
19 Yano Y, Bakris GL, Matsushita K, Hoshide S, et al. Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly. Am J Nephrol 2013; 38 (3): 195-203.
20 Badayeva SV. Risk factors for myocardial hypertrophy in chronic kidney disease. Nephrology and dialysis 2008; 10 (2): 94-104
21 Wohlfahrt Р, Rokosny S, Melenovsky V, et al. Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease. Hypertens Res 2016; 39: 654-9
22 Liao R, Wang L, Li, J et al. Hemodialysis access type is associated with blood pressure variability and echocardiographic changes in end-stage renal disease patients. J Nephrol 2019 Jan 21 DOI: 10.1007/s40620-018-00574-y
23 McCullough PA, Chan CT, et al. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. Am J Kidney Dis2016;68:S5-S14
24 Liang X, Wang W, Li H. Water and sodium restriction on cardiovascular disease in young chronic hemodialysis patients. Chin Med J (Engl) 2013; 126 (9): 1667-72
25 Wang AY, Chan JC, Wang M, et al. Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 2003; 63 (5): 1899-907. http://dx.doi.Org/1 0.1 046/J.1 523-1 755.2003.00933.x
26 Naydich AM, Chestukhina OV, et al. Left ventricular hypertrophy induced by a chronic kidney disease and structurally functional remodeling of a myocardium. Nephrology and dialysis 2005; 71): 46-53
27 Smirnov AV, Volkov MM, Dobronravov VA. Cardiopro-tective effects of D-hormone at patients with chronic kidney disease. Nephrology 2009; 13 (1): 30-8
28 Linden Е, Cai W, Не JC, et al. Endotelial dysfunction in patients with chronic kidney disease results from advanced glyca-tion end products (AGE) — mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 2008; 3 (3): 691-8.
29 Karabaeva AZh, Esaian AM, Kaiukov IG. The characteristics of left ventricular myocardial remodeling in patients with chronic renal disease, and the effects of spironolactone therapy. Klin Med (Moscow) 2007; 85 (12): 44-8
30 Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83
31 Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7 (2):79-108
32 Park M, Hsu CY, Li Y, et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012; 23: 1725-34
33 Bansal N, Keane M, Delafontaine P, et al. A longitudinal study of left ventricular function and structure from CKD to ESRD: The CRIC study. Clin J Am Soc Nephrol 2013; 8: 355-62
34 Ha SK, Park HS, Kim SJ, et al. Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure. J Korean Med Sci 1998; 13: 488-94
35 de Roij van Zuijdewijn CL, Hansildaar R, Bots ML, et al. Eccentric left ventricular hypertrophy and sudden death in patients with end-stage kidney disease. Am J Nephrol 2015; 42: 126-33
36 Dimitrijevic Z, Cvetkovic T, Stojanovic M, et al. Prevalence and risk factors of myocardial remodeling in hemodialysis patients. Ren Fail 2009; 31: 662-7
37 Nube MJ, Hoekstra T, Doganer V, et al. Left ventricular geometric patterns in end-stage kidney disease: Determinants and course overtime. Hemodial Int 2018 Jul; 22 (3): 359-68. DOI: 10.1111/hdi.12644
38 Chen SC, Su HM, Hung CC, et al. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2750-8. DOI: 10.2215/CJN.04660511
39 Eckardt KU, Scherhag A, Macdougall 1С, et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol 2009; 20: 2651 -60
40 Lieb W, Gona P, Larson MG, et al. The natural history of left ventricular geometry in the community: Clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging 2014; 7: 870-8
41 Shakhov BE, Belousov YuV, Demidova NYu. Echocardiographic criteria of «hypertensive heart». N. Novgorod: NGMA publishing house, 2009; 184 p.
42 Suslova ОА., Zubeeva GN., Kuzmenko YuN, et al. Left ventricular remodeling in patients with end-stage kidney disease corrected by chronic hemodialysis. Modern technologies in medicine 2014; 6 (4): 160-6
43 Cai QZ, Lu XZ, Lu Y, Wang AY. Longitudinal changes of cardiac structure and function in CKD (CASCADE study). J Am Soc Nephrol 2014; 25: 1599-608.44 Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE. Sudden cardiac death in end-stage renal disease patients: A 5-year prospective analysis. Hypertension 2010; 56: 210-6
45 Malik J. Heart disease in chronic kidney disease: Review of the mechanisms and the role of dialysis access. J Vase Access 2017Nov29;0. DOI: 10.5301/jva.5000815
46 Hwang HS, Cho JS, Hong YA, et al. Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts. Int J Med Sci 2018 Mar 9; 15 (6): 557-63. DOI: 10.7150/ijms.23700
47 Ellouali F, Berkchi F, Elhoussni S, et al. Evaluation of the effect of duration on dialysis on echocardiographic parameters: A preliminary study. Saudi J Kidney Dis Transpl 2015; 26: 83-9
48 Ayman M. El-Badawy, Ahmed E. Mansour, Rasha O. Ab-delmoniem, Asmaa El-Seedawy Rabee. Effect of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients. Journal of the Egyptian Society of Nephrology and Transplantation 2018, 18: 40-5
49 Cavalcante LG, Ricardo de Souza C, Kochi AC, et al. Left ventricular mass behaviour in hemodialysis patients during 17 years. J Bras Nefrol 2015 Jul-Sep; 37 (3): 341-8. DOI: 10.5935/0101 -2800.20150054
50 Albeshri MA, Alsallum MS, Sindi S, et al. Hospitalization rate and outcomes in patients with left ventricular dysfunction receiving hemodialysis. Int J Gen Med 2018 Dec 6; 11: 463-72. DOI: 10.2147/IJGM.S179206
51 Dudar MM., Fendrikova AV, Arutyunov AK, et al. Left ventricular function in patients with cardiorenal pathology and chronic renal failure. Rossiyskiy kardiologicheskiy zhur-nal 2006; 3: 26-9
52 Komissarov KS. The effect of dialysis therapy on the left ventricle in end-stage renal disease patients. Be- lorusskij medicinskij zhurnal 2004; 3: 56-8. Russian (Комиссаров К. С. Влияние методов диализотерапии на состояние левого желудочка сердца у больных с терминальной почечной недостаточностью. Белорусский медицинский журнал 2004; 3: 56-8/

2019_02_217-221.pdf306.44 KB

No votes yet